<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain Sci</journal-id>
<journal-id journal-id-type="publisher-id">brainsci</journal-id>
<journal-title-group>
<journal-title>Brain Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">2076-3425</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32235346</article-id>
<article-id pub-id-type="pmc">7226514</article-id>
<article-id pub-id-type="doi">10.3390/brainsci10040200</article-id>
<article-id pub-id-type="publisher-id">brainsci-10-00200</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptomic Analysis Reveals Abnormal Expression of Prion Disease Gene Pathway in Brains from Patients with Autism Spectrum Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6723-7019</contrib-id>
<name>
<surname>Lombardo</surname>
<given-names>Salvo Danilo</given-names>
</name>
<xref ref-type="aff" rid="af1-brainsci-10-00200">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Battaglia</surname>
<given-names>Giuseppe</given-names>
</name>
<xref ref-type="aff" rid="af2-brainsci-10-00200">2</xref>
<xref ref-type="aff" rid="af3-brainsci-10-00200">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Petralia</surname>
<given-names>Maria Cristina</given-names>
</name>
<xref ref-type="aff" rid="af4-brainsci-10-00200">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5920-4620</contrib-id>
<name>
<surname>Mangano</surname>
<given-names>Katia</given-names>
</name>
<xref ref-type="aff" rid="af1-brainsci-10-00200">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Basile</surname>
<given-names>Maria Sofia</given-names>
</name>
<xref ref-type="aff" rid="af1-brainsci-10-00200">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bruno</surname>
<given-names>Valeria</given-names>
</name>
<xref ref-type="aff" rid="af2-brainsci-10-00200">2</xref>
<xref ref-type="aff" rid="af3-brainsci-10-00200">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6694-1992</contrib-id>
<name>
<surname>Fagone</surname>
<given-names>Paolo</given-names>
</name>
<xref ref-type="aff" rid="af1-brainsci-10-00200">1</xref>
<xref ref-type="corresp" rid="c1-brainsci-10-00200">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bella</surname>
<given-names>Rita</given-names>
</name>
<xref ref-type="aff" rid="af5-brainsci-10-00200">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4570-8462</contrib-id>
<name>
<surname>Nicoletti</surname>
<given-names>Ferdinando</given-names>
</name>
<xref ref-type="aff" rid="af1-brainsci-10-00200">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cavalli</surname>
<given-names>Eugenio</given-names>
</name>
<xref ref-type="aff" rid="af1-brainsci-10-00200">1</xref>
</contrib>
</contrib-group>
<aff id="af1-brainsci-10-00200"><label>1</label>Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy; <email>salvo.lombardo.sdl@gmail.com</email> (S.D.L.); <email>kmangano@unict.it</email> (K.M.); <email>sofiabasile@hotmail.it</email> (M.S.B.); <email>ferdinic@unict.it</email> (F.N.); <email>eugeniocavalli9@hotmail.it</email> (E.C.)</aff>
<aff id="af2-brainsci-10-00200"><label>2</label>Department of Physiology and Pharmacology, University Sapienza, Piazzale A. Moro, 5, 00185 Roma, Italy; <email>giuseppe.battaglia@uniroma1.it</email> (G.B.); <email>valeria.bruno@uniroma1.it</email> (V.B.)</aff>
<aff id="af3-brainsci-10-00200"><label>3</label>IRCCS Neuromed, Località Camerelle, 86077 Pozzilli, Italy</aff>
<aff id="af4-brainsci-10-00200"><label>4</label>Department of Educational Sciences, University of Catania, 95124 Catania, Italy; <email>m.cristinapetralia@gmail.com</email></aff>
<aff id="af5-brainsci-10-00200"><label>5</label>Department of Medical Sciences, Surgery and Advanced Technologies, University of Catania, 95123 Catania, Italy; <email>rbella@unict.it</email></aff>
<author-notes>
<corresp id="c1-brainsci-10-00200"><label>*</label>Correspondence: <email>paolofagone@yahoo.it</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>4</month>
<year>2020</year>
</pub-date>
<volume>10</volume>
<issue>4</issue>
<elocation-id>200</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>2</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>3</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 by the authors.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>The role of infections in the pathogenesis of autism spectrum disorder (ASD) is still controversial. In this study, we aimed to evaluate markers of infections and immune activation in ASD by performing a meta-analysis of publicly available whole-genome transcriptomic datasets of brain samples from autistic patients and otherwise normal people. Among the differentially expressed genes, no significant enrichment was observed for infectious diseases previously associated with ASD, including herpes simplex virus-1 (HSV-1), cytomegalovirus and Epstein–Barr virus in brain samples, nor was it found in peripheral blood from ASD patients. Interestingly, a significant number of genes belonging to the “prion diseases” pathway were found to be modulated in our ASD brain meta-analysis. Overall, our data do not support an association between infection and ASD. However, the data do provide support for the involvement of pathways related to other neurodegenerative diseases and give input to uncover novel pathogenetic mechanisms underlying ASD.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>infection</kwd>
<kwd>prion</kwd>
<kwd>meta-analysis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-brainsci-10-00200" sec-type="intro">
<title>1. Introduction</title>
<p>Autism spectrum disorder (ASD) is a heterogeneous group of neurodevelopmental disorders defined by significantly abnormal social interaction, impaired communication and language abilities, and a narrow pattern of interests [<xref ref-type="bibr" rid="B1-brainsci-10-00200">1</xref>]. It is estimated that the prevalence of ASD is 1%–2% in the general population with an average male-to-female ratio of 5:1 [<xref ref-type="bibr" rid="B2-brainsci-10-00200">2</xref>]. However, only about 10% of patients with a diagnosis of ASD have a defined etiology (so-called syndromic autism, secondary to Fragile X syndrome, neurofibromatosis and exposure to thalidomide) [<xref ref-type="bibr" rid="B3-brainsci-10-00200">3</xref>], while 90% of ASD cases are considered idiopathic.</p>
<p>Many authors have hypothesized a connection between genetic and epigenetic factors in ASD etiopathogenesis. In particular, infections have been suggested as a potential trigger of the disease [<xref ref-type="bibr" rid="B4-brainsci-10-00200">4</xref>,<xref ref-type="bibr" rid="B5-brainsci-10-00200">5</xref>,<xref ref-type="bibr" rid="B6-brainsci-10-00200">6</xref>]. In line with this, altered cellular immunity and an altered cytotoxic function of natural killer (NK) cells have been reported in ASD patients [<xref ref-type="bibr" rid="B7-brainsci-10-00200">7</xref>,<xref ref-type="bibr" rid="B8-brainsci-10-00200">8</xref>,<xref ref-type="bibr" rid="B9-brainsci-10-00200">9</xref>]. It has also been shown that fungal mycotoxins, such as deoxynivalenol in urine and Ochratoxin A in serum, are increased in autistic children [<xref ref-type="bibr" rid="B10-brainsci-10-00200">10</xref>,<xref ref-type="bibr" rid="B11-brainsci-10-00200">11</xref>]. Finally, expression of immune response genes has been described in cortical tissues from older ASD subjects [<xref ref-type="bibr" rid="B12-brainsci-10-00200">12</xref>,<xref ref-type="bibr" rid="B13-brainsci-10-00200">13</xref>].</p>
<p>In the present study, we investigated the expression levels of transcriptional markers of infections and immune activation in brain and blood samples from autistic patients by performing a meta-analysis of publicly available whole-genome expression datasets. The analysis of the data suggests common transcriptional features between ASD and prion-related diseases but does not support the role of infectious disease in the etiopathogenesis of ASD.</p>
</sec>
<sec id="sec2-brainsci-10-00200">
<title>2. Materials and Methods</title>
<sec id="sec2dot1-brainsci-10-00200">
<title>2.1. Data Collection and Metanalysis</title>
<p>The NCBI (National Center for Biotechnology Information) Gene Expression Omnibus (GEO) database (<uri xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</uri>) was used to identify microarray datasets comparing the transcriptomic profiles of healthy donors and ASD patients. The GEO database was manually searched using the terms “autism” and “autistic disorder”. The collected datasets were further selected if they met the following inclusion criteria: (a) whole-genome transcriptomic profiling; (b) brain or blood samples; (c) consisted of one cohort of ASD patients and another cohort of healthy people; and (d) species of origin was “<italic>Homo sapiens</italic>”. Finally, five datasets were included in the meta-analysis of brain samples: GSE28521, GSE38322, GSE62098, GSE64018 and GSE102741, while three datasets were used for the meta-analysis of blood samples: GSE6575, GSE42133 and GSE18123. When a dataset included more than one tissue type, data from each tissue type were processed as a separate dataset. The datasets were uploaded to NetworkAnalyst 3.0 software (Ste. Anne de Bellevue, Quebec, Canada). Data were auto-scaled, and an integrity check was performed prior to the meta-analysis stage. Batch effects were corrected using the “ComBat” function. A random effects model of effect size (ES) measure was used to integrate gene expression patterns from the three datasets. The random effects model presumes that different studies present substantial diversity and evaluates between-study variance as well as within-study sampling error. Genes with a False Discovery Rate (FDR) &lt; 0.05 were identified as differentially expressed genes (DEGs) and selected for further analysis. The characteristics of the samples in the datasets used are described in <xref ref-type="table" rid="brainsci-10-00200-t001">Table 1</xref>.</p>
</sec>
<sec id="sec2dot2-brainsci-10-00200">
<title>2.2. Pathway Selection and Gene Intersection</title>
<p>Pathway enrichment analysis was performed using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (<uri xlink:href="https://www.genome.jp/kegg/">https://www.genome.jp/kegg/</uri>) implemented in the Enrichr (<uri xlink:href="http://amp.pharm.mssm.edu/Enrichr">http://amp.pharm.mssm.edu/Enrichr</uri>) web-based utility [<xref ref-type="bibr" rid="B24-brainsci-10-00200">24</xref>]. Higher-level biological functions are represented by networks of molecular interactions, reactions and relations that are integrated in the pathways from the KEGG database. KEGG integrates the current knowledge on molecular interaction networks and uses a knowledge-based approach for network prediction that aims to predict, given a complete set of genes in the genome, the protein interaction networks that are responsible for various cellular processes [<xref ref-type="bibr" rid="B25-brainsci-10-00200">25</xref>]. Enrichr computes the <italic>p</italic> value using the Fisher exact test. The adjusted <italic>p</italic> value is calculated using the Benjamini–Hochberg method for correction for multiple hypotheses testing. The z-score is computed using a modification to the Fisher exact test and assesses the deviation from the expected rank. Finally, the combined score is calculated using the <italic>p</italic> value and the z-score (Combined Score = ln(<italic>p</italic> value) × z-score).</p>
</sec>
<sec id="sec2dot3-brainsci-10-00200">
<title>2.3. Machine Learning Prediction and Network Construction</title>
<p>The webtool “ASD Genome-wide predictions of autism-associated genes” was used to evaluate the probability value of association between the selected gene and ASD. This webtool is based on a machine learning approach that, using a Bayesian method, allows the user to predict the role of candidate genes [<xref ref-type="bibr" rid="B26-brainsci-10-00200">26</xref>]. Briefly, Krishnan et al. developed an evidence-weighted, network-based machine-learning method that uses this brain-specific network to systematically discover new candidate ASD risk genes across the genome. The brain-specific network was constructed using a Bayesian method that extracts and integrates brain-specific functional signals from a gene-interaction network model containing predicted functional relationships for all pairs within 25,825 genes in the human genome. In order to produce a comprehensive, robust, genome-wide ranked list of autism candidate genes, Krishnan et al. first curated 594 genes linked with autism from publicly available databases and based on the strength of evidence of association with ASD. Next, an evidence-weighted support vector machine classifier, using the connectivity of genes to all the genes in the human brain-specific network, was employed to identify novel ASD candidates, defined as those genes whose interaction features in the network most closely resemble those of known ASD-related genes [<xref ref-type="bibr" rid="B26-brainsci-10-00200">26</xref>].</p>
</sec>
<sec id="sec2dot4-brainsci-10-00200">
<title>2.4. Statistical Analysis</title>
<p>For the meta-analysis, a random-effect model of effect size measure was used to integrate gene expression patterns from the selected datasets. Genes with an adjusted <italic>p</italic> value (FDR, q-value) &lt; 0.05 were identified as DEGs and selected for further analysis. Pathway enrichment analysis was performed using the online server Enrichr (<uri xlink:href="http://amp.pharm.mssm.edu/Enrichr">http://amp.pharm.mssm.edu/Enrichr</uri>) [<xref ref-type="bibr" rid="B24-brainsci-10-00200">24</xref>]. For all the analyses, an adjusted <italic>p</italic> value ≤ 0.05 was considered as the statistical significance threshold.</p>
</sec>
</sec>
<sec id="sec3-brainsci-10-00200" sec-type="results">
<title>3. Results</title>
<sec id="sec3dot1-brainsci-10-00200">
<title>3.1. Identification of an ASD Brain Transcriptomic Profile</title>
<p>Five GEO whole-genome transcriptomic datasets were identified (see <xref ref-type="table" rid="brainsci-10-00200-t001">Table 1</xref>) and used in the following analysis. These datasets included 84 brain samples from ASD patients (<italic>n</italic> = 55 unique patients) and 109 brain samples from otherwise normal people (<italic>n</italic> = 81 unique subjects). The meta-analysis identified 516 DEGs: 218 upregulated and 298 downregulated. The most enriched pathways were represented by “Synaptic vesicle cycle”, “Huntington’s disease” and “Sphingolipid signaling pathway” (<xref ref-type="table" rid="brainsci-10-00200-t002">Table 2</xref>).</p>
<p><xref ref-type="fig" rid="brainsci-10-00200-f001">Figure 1</xref> shows the results from the enrichment analysis for infectious-related pathways enlisted in the KEGG database. No significant enrichment was observed among the DEGs with the exception of the “prion diseases” pathway (q = 0.038) (<xref ref-type="fig" rid="brainsci-10-00200-f001">Figure 1</xref> and <xref ref-type="fig" rid="brainsci-10-00200-f002">Figure 2</xref>; <xref ref-type="app" rid="app1-brainsci-10-00200">Supplementary File 1</xref>). In particular, in the “prion diseases” pathway, our analysis identified significantly higher levels of Complement Component 1, q Subcomponent, B Chain (C1QB), Heat Shock Protein Family A Member 5 (HSPA5), Proto-Oncogene Tyrosine-Protein kinase Fyn (FYN), Laminin Subunit Gamma 1 (LAMC1) and ETS Like-1 Protein (ELK1) and significantly lower levels of Mitogen-Activated Protein Kinase 1 (MAP2K1) (<xref ref-type="fig" rid="brainsci-10-00200-f002">Figure 2</xref>).</p>
<p>We next wanted to evaluate the enrichment of immune-related processes among the ASD brain DEGs. As shown in <xref ref-type="fig" rid="brainsci-10-00200-f003">Figure 3</xref>, only the “Sphingolipid signaling pathway” was significantly enriched, encompassing four downregulated DEGs (MAP2K1, Protein Kinase C Beta (PRKCB), Sphingosine Kinase 2 (SPHK2), Ras-Related C3 Botulinum Toxin Substrate 3 (RAC3)) and six upregulated DEGs (G Protein Subunit Alpha I3 (GNAI3), Sphingosine-1-phosphate receptor 1 (S1PR1), FYN, Rapidly Accelerated Fibrosarcoma 1 (RAF1), TNF Receptor Superfamily Member 1A (TNFRSF1A), G Protein Subunit Alpha I2 (GNAI2)).</p>
</sec>
<sec id="sec3dot2-brainsci-10-00200">
<title>3.2. Machine Learning Prediction</title>
<p>The brain autism DEGs belonging to the “prion diseases” pathway from the Kyoto Encyclopedia of Genes and Genomes (KEGG) were investigated for their potential role in ASD using a network machine learning approach implemented in the “ASD Genome-wide predictions of autism-associated genes” web-tool (<uri xlink:href="http://asd.princeton.edu/">http://asd.princeton.edu/</uri>). The network constructed using the brain ASD DEGs belonging to the “prion diseases” pathway is presented as <xref ref-type="fig" rid="brainsci-10-00200-f004">Figure 4</xref>. Among the input genes, the only one significantly associated with ASD is FYN, with an estimated probability of 0.665 and a q-value = 0.0256. <xref ref-type="table" rid="brainsci-10-00200-t003">Table 3</xref> shows the genes mostly interacting with the input genes, ordered by the edge score. The prioritization and prediction of ranking is based on the network-based approach developed by Krishnan et al. [<xref ref-type="bibr" rid="B26-brainsci-10-00200">26</xref>]. Among the top-ranking ASD genes associated with the DEGs belonging to the “prion diseases” pathway, Mesencephalic Astrocyte Derived Neurotrophic Factor (MANF), Heat Shock Protein 90 Beta Family Member 1 (HSP90B1) and Mitogen-Activated Protein Kinase 1 (MAPK1) showed edge scores of 0.791, 0.79 and 0.789 with HSPA5, HSPA5 and MAP2K1, respectively (<xref ref-type="table" rid="brainsci-10-00200-t003">Table 3</xref>). The top-ranking ASD gene interacting with the DEGs belonging to the “prion diseases” pathway is Ataxin 1 (ATXN1), with a rank position of 5, a probability value of association with ASD of 0.808 and a q-value = 0.0186. ATXN1 was the most connected gene to FYN (edge score 0.705) (<xref ref-type="table" rid="brainsci-10-00200-t004">Table 4</xref>). None of the predicted top 10 genes are present in the Genome-Wide Association Study (GWAS) Catalog 2019.</p>
</sec>
<sec id="sec3dot3-brainsci-10-00200">
<title>3.3. Identification of an ASD Blood Transcriptomic Profile</title>
<p>Three GEO whole-genome transcriptomic datasets, GSE6575, GSE42133 and GSE18123, were identified, as indicated in <xref ref-type="table" rid="brainsci-10-00200-t001">Table 1</xref>, for the following analysis. These datasets included blood samples from 157 ASD patients and blood samples from 101 otherwise normal people. The meta-analysis identified only 24 DEGs: 19 upregulated and 5 downregulated. As shown in <xref ref-type="table" rid="brainsci-10-00200-t005">Table 5</xref>, no significant enrichment for any KEGG pathway was detected (<xref ref-type="table" rid="brainsci-10-00200-t005">Table 5</xref>).</p>
</sec>
</sec>
<sec id="sec4-brainsci-10-00200" sec-type="discussion">
<title>4. Discussion</title>
<p>According to the current DSM-5 criteria, two requirements are needed to obtain an ASD diagnosis: (1) persistent deficits in social communication and social interaction across multiple contexts, and (2) restricted, repetitive patterns of behavior, interests or activities [<xref ref-type="bibr" rid="B1-brainsci-10-00200">1</xref>]. Although ASD has a complex multifactorial etiology, twin studies have proven a strong genetic contribution, with a concordance rate of autistic disorders in monozygotic twins of 70%–90% and in dizygotic twins of 30% [<xref ref-type="bibr" rid="B27-brainsci-10-00200">27</xref>,<xref ref-type="bibr" rid="B28-brainsci-10-00200">28</xref>].</p>
<p>However, the complexity of the disease requires omics approaches to integrate and extrapolate more information. Genome-wide association studies, candidate gene studies and microarray experiments of differential gene expression have been largely used in autism. These studies produce extensive and information-rich data that represent a snapshot of all genetic and/or molecular events occurring in a diseased cell at one particular point in time and can be used to generate hypotheses. The use of whole-genome expression databases has been largely exploited by our group and others [<xref ref-type="bibr" rid="B29-brainsci-10-00200">29</xref>,<xref ref-type="bibr" rid="B30-brainsci-10-00200">30</xref>,<xref ref-type="bibr" rid="B31-brainsci-10-00200">31</xref>,<xref ref-type="bibr" rid="B32-brainsci-10-00200">32</xref>,<xref ref-type="bibr" rid="B33-brainsci-10-00200">33</xref>] for the characterization of the etiopathogenesis of a variety of diseases (e.g., autoimmune diseases [<xref ref-type="bibr" rid="B34-brainsci-10-00200">34</xref>,<xref ref-type="bibr" rid="B35-brainsci-10-00200">35</xref>,<xref ref-type="bibr" rid="B36-brainsci-10-00200">36</xref>,<xref ref-type="bibr" rid="B37-brainsci-10-00200">37</xref>,<xref ref-type="bibr" rid="B38-brainsci-10-00200">38</xref>,<xref ref-type="bibr" rid="B39-brainsci-10-00200">39</xref>,<xref ref-type="bibr" rid="B40-brainsci-10-00200">40</xref>,<xref ref-type="bibr" rid="B41-brainsci-10-00200">41</xref>,<xref ref-type="bibr" rid="B42-brainsci-10-00200">42</xref>] and cancer [<xref ref-type="bibr" rid="B36-brainsci-10-00200">36</xref>,<xref ref-type="bibr" rid="B43-brainsci-10-00200">43</xref>,<xref ref-type="bibr" rid="B44-brainsci-10-00200">44</xref>]) and has allowed researchers to characterize pathogenic pathways [<xref ref-type="bibr" rid="B45-brainsci-10-00200">45</xref>,<xref ref-type="bibr" rid="B46-brainsci-10-00200">46</xref>,<xref ref-type="bibr" rid="B47-brainsci-10-00200">47</xref>,<xref ref-type="bibr" rid="B48-brainsci-10-00200">48</xref>] and potential novel therapeutic targets [<xref ref-type="bibr" rid="B49-brainsci-10-00200">49</xref>,<xref ref-type="bibr" rid="B50-brainsci-10-00200">50</xref>,<xref ref-type="bibr" rid="B51-brainsci-10-00200">51</xref>,<xref ref-type="bibr" rid="B52-brainsci-10-00200">52</xref>,<xref ref-type="bibr" rid="B53-brainsci-10-00200">53</xref>,<xref ref-type="bibr" rid="B54-brainsci-10-00200">54</xref>,<xref ref-type="bibr" rid="B55-brainsci-10-00200">55</xref>,<xref ref-type="bibr" rid="B56-brainsci-10-00200">56</xref>,<xref ref-type="bibr" rid="B57-brainsci-10-00200">57</xref>].</p>
<p>Many authors have suggested that the role of infection during pregnancy or in the first phases of life could trigger the immune system to alter normal neurodevelopment, causing neuronal damage [<xref ref-type="bibr" rid="B8-brainsci-10-00200">8</xref>,<xref ref-type="bibr" rid="B58-brainsci-10-00200">58</xref>,<xref ref-type="bibr" rid="B59-brainsci-10-00200">59</xref>]. In particular, the role of the Herpesviridae family has been largely investigated. For instance, cytomegalovirus (CMV) can directly damage key structures in the developing brain when contracted during pregnancy [<xref ref-type="bibr" rid="B60-brainsci-10-00200">60</xref>], and indeed, in vitro studies have shown that CMV infection can inhibit neuronal differentiation and induce apoptosis in neural precursor cells [<xref ref-type="bibr" rid="B61-brainsci-10-00200">61</xref>,<xref ref-type="bibr" rid="B62-brainsci-10-00200">62</xref>]. Also, other infectious diseases such as influenza A [<xref ref-type="bibr" rid="B58-brainsci-10-00200">58</xref>], toxoplasmosis [<xref ref-type="bibr" rid="B63-brainsci-10-00200">63</xref>,<xref ref-type="bibr" rid="B64-brainsci-10-00200">64</xref>] and measles [<xref ref-type="bibr" rid="B6-brainsci-10-00200">6</xref>,<xref ref-type="bibr" rid="B65-brainsci-10-00200">65</xref>] are suspected to be related to ASD.</p>
<p>However, the role of infections in the pathogenesis of autism is still highly debated. The levels of D-arabinitol, a marker of candidiasis fungal infection, as well as of a phenylalanine metabolite of <italic>Clostridia</italic> species, the 3-(3-hydroxyphenyl)-3-hydroxypropionic acid, are increased in the urine of autistic children [<xref ref-type="bibr" rid="B66-brainsci-10-00200">66</xref>,<xref ref-type="bibr" rid="B67-brainsci-10-00200">67</xref>]. Accumulating evidence also suggests that latent chronic toxoplasmosis plays a role in the triggering and development of many psychiatric and neurological disorders, including ASD [<xref ref-type="bibr" rid="B68-brainsci-10-00200">68</xref>]. On the other hand, other studies have not shown a significant prevalence of infections in ASD [<xref ref-type="bibr" rid="B5-brainsci-10-00200">5</xref>,<xref ref-type="bibr" rid="B69-brainsci-10-00200">69</xref>,<xref ref-type="bibr" rid="B70-brainsci-10-00200">70</xref>,<xref ref-type="bibr" rid="B71-brainsci-10-00200">71</xref>]. The aim of our analysis was to evaluate, by performing a meta-analysis of available whole-genome transcriptomic datasets, whether infection alone or infection and immune activation processes could be detected in the brains or peripheral blood of autistic patients. To our knowledge, this is the largest meta-analysis of both ASD brain samples and leukocytes to date.</p>
<p>In our study, no significant enrichment for infection-related pathways, including Epstein-Barr virus (EBV), CMV, HSV-1, measles, influenza A and toxoplasmosis, was found among the DEGs identified in the meta-analyses. On the other hand, a significant enrichment of the “prion diseases” pathway was observed. However, it should be pointed out that, with the present data, it is currently not possible to identify ASD as a prion-related disease, but it is possible to describe common biomolecular pathways underlying ASD pathogenesis. Indeed, prion infection is known to affect microglial sensing and homeostasis ability and to reduce microglial phagocytosis of aberrant proteins, including PrPsc (scrapie isoform of the prion protein) and apoptotic debris or cells, despite production of proinflammatory mediators. Furthermore, the effects of PrPsc on microglia appear to be mediated by Toll-like Receptors (TLRs) in a Src-like kinase-dependent manner (reviewed in [<xref ref-type="bibr" rid="B72-brainsci-10-00200">72</xref>]). So, it may not be surprising to find that prion pathways are modified in the brains of ASD patients, as it may reflect prior inflammatory processes, having modified microglia.</p>
<p>In the present paper, we have combined transcriptomic meta-analysis, pathway enrichment and machine learning prediction in order to prioritize genes of interest with potential pivotal pathogenetic effects in autism. Computational methods have been largely used to investigate the etiopathogenesis of polygenic and idiopathic disorders. Functional interaction networks that integrate gene interaction data can be exploited to identify which genes are most strongly implicated in a disorder. Given a list of genes that are altered in a disease, we can apply methods to identify genes that are near the input genes within a functional interaction network that rely on the connections among genes in a functional interaction network. The major limitation of this kind of approach is that it relies on the methods of selection by which functional terms are included in the network-based prediction. Hence, the better tailored this set of genes is to the disease of interest, the higher reliability we have in the final predictions. The use of the machine learning prediction tool developed by Krishnan and colleagues [<xref ref-type="bibr" rid="B26-brainsci-10-00200">26</xref>] allows us to evaluate the probability value of association between the selected gene and ASD in the context of the human brain-specific network. With this approach, we likely arrive at a robust set of candidates that are relatively unbiased by previously published works. The final output of this strategy, i.e., a ranked list of candidate genes, is easy to interpret and provides a limited set of hypotheses to test in further investigations. However, while we cannot definitively identify the causal gene or genes, it does provide a much-reduced set of candidates to investigate. In particular, a role for tyrosine kinase Fyn is proposed. Fyn has been described as expressed in the mouse hippocampus, amygdala and cerebellum [<xref ref-type="bibr" rid="B73-brainsci-10-00200">73</xref>,<xref ref-type="bibr" rid="B74-brainsci-10-00200">74</xref>]. Mutations of Fyn in mice lead to alteration in the architecture of the hippocampus [<xref ref-type="bibr" rid="B75-brainsci-10-00200">75</xref>] with consequent impairment in learning and in the amygdala long-term plasticity [<xref ref-type="bibr" rid="B73-brainsci-10-00200">73</xref>]. Fyn regulates the focal adhesion kinase (FAK), which is required for normal neuronal development [<xref ref-type="bibr" rid="B73-brainsci-10-00200">73</xref>,<xref ref-type="bibr" rid="B76-brainsci-10-00200">76</xref>].</p>
<p>In our analysis, Fyn was strongly correlated with ATXN1, a DNA-binding protein that forms a transcriptional repressor complex with capicua (CIC). It has been previously described that the deletion in chromosome 6p22.3-p24.3, which harbors ATXN1, is associated with developmental delay and ASD [<xref ref-type="bibr" rid="B77-brainsci-10-00200">77</xref>,<xref ref-type="bibr" rid="B78-brainsci-10-00200">78</xref>]. Moreover, alteration of the ATXN1-CIC complex determines a spectrum of neurobehavioral phenotypes, including intellectual disability, attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder [<xref ref-type="bibr" rid="B79-brainsci-10-00200">79</xref>].</p>
<p>Finally, we need to address some important limitations to our study. First, the number of available gene expression datasets of brain samples derived from ASD patients is limited, and the number of samples included in each dataset is often negligible. Second, the meta-analysis here performed encompasses different brain regions (temporal, occipital and frontal cortex, as well as corpus callosum and cerebellum). These facts undermine the statistical power of the differential expression analysis and impede patients’ stratification, in terms of clinical phenotype, which is advisable given the heterogeneity of ASD. It is likely that different subgroups of patients may have peculiar brain transcriptomic patterns. Moreover, gene expression analysis is not enough to determine whether particular biological processes are activated or not, limiting the reliability of the conclusions that can be drawn. Hence, more population- and molecular-based studies are warranted to confirm or negate hypotheses.</p>
<p>Characterizing molecular pathways underlying ASD represents a crucial step for personalized medicine where comprehensive phenotyping of individual patients could be available, providing novel tailored treatment options. The data from this study suggest that infections may not necessarily be responsible for ASD development. However, since some genes involved in the infectious processes can interact with other key genes in autism, infections may likely act as co-factors, possibly causing worse clinical presentations. Future studies are necessary to validate these findings and prove if these genes can be used as biomarkers or even as eventual therapeutic targets. Finally, we have to point out that the present analysis cannot evaluate the potential role of infections in the prenatal period or contracted in the early stage of life.</p>
</sec>
<sec id="sec5-brainsci-10-00200" sec-type="conclusions">
<title>5. Conclusions</title>
<p>In this paper, we investigated the relationship between infections and autism, proving that they should not be considered as etiological factors but probably as co-factors. We analyzed the gene expression profiles of brain and blood from autistic patients and compared them with the genes involved in the most frequent infectious diseases associated with pregnancy and suspected to be related to ASD. Our analysis does not show any statistically significant associations between ASD and previously studied infectious agents. However, it does show a statistical association between prion disease and autism. Finally, based on a Bayesian machine learning approach, we predicted that new genes may be associated with ASD and possibly, after validation, used as markers or therapeutic targets.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>Not applicable.</p>
</ack>
<app-group>
<app id="app1-brainsci-10-00200">
<title>Supplementary Materials</title>
<p>The following are available online at <uri xlink:href="https://www.mdpi.com/2076-3425/10/4/200/s1">https://www.mdpi.com/2076-3425/10/4/200/s1</uri>: File 1: Prion diseases pathway.</p>
<supplementary-material content-type="local-data" id="brainsci-10-00200-s001">
<media xlink:href="brainsci-10-00200-s001.xlsx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</app>
</app-group>
<notes>
<title>Author Contributions</title>
<p>Conceptualization, S.D.L., P.F. and E.C.; Data curation, M.C.P. and M.S.B.; Formal analysis, S.D.L. and P.F.; Funding acquisition, G.B. and V.B.; Supervision, F.N.; Visualization, S.D.L.; Writing—original draft, S.D.L., M.C.P., M.S.B. and E.C.; Writing—review &amp; editing, G.B., K.M., V.B., P.F., R.B. and F.N. All authors have read and agreed to the published version of the manuscript.</p>
</notes>
<notes>
<title>Funding</title>
<p>This study was supported by current research funds 2019 of IRCCS “NEUROMED—Mediterranean Neurological Institute”, Pozzilli, Italy.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflicts of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-brainsci-10-00200">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Autism</article-title>
<source/>Proc. Lancet
          <year>2014</year>
<volume>383</volume>
<fpage>896</fpage>
<lpage>910</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(13)61539-1</pub-id>
</element-citation>
</ref>
<ref id="B2-brainsci-10-00200">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiśniowiecka-Kowalnik</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nowakowska</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Genetics and epigenetics of autism spectrum disorder—Current evidence in the field</article-title>
<source/>J. Appl. Genet.
          <year>2019</year>
<volume>60</volume>
<fpage>37</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1007/s13353-018-00480-w</pub-id>
<pub-id pub-id-type="pmid">30627967</pub-id>
</element-citation>
</ref>
<ref id="B3-brainsci-10-00200">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benvenuto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Moavero</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Alessandrelli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Manzi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Curatolo</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Syndromic autism: Causes and pathogenetic pathways</article-title>
<source/>World J. Pediatr.
          <year>2009</year>
<volume>5</volume>
<fpage>169</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1007/s12519-009-0033-2</pub-id>
<pub-id pub-id-type="pmid">19693459</pub-id>
</element-citation>
</ref>
<ref id="B4-brainsci-10-00200">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gentile</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zappulo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Militerni</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pascotto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Borgia</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bravaccio</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Etiopathogenesis of autism spectrum disorders: Fitting the pieces of the puzzle together</article-title>
<source/>Med. Hypotheses
          <year>2013</year>
<volume>81</volume>
<fpage>26</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2013.04.002</pub-id>
<pub-id pub-id-type="pmid">23622947</pub-id>
</element-citation>
</ref>
<ref id="B5-brainsci-10-00200">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sweeten</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Windham</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Odell</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Stubbs</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Brief Report: Low Rates of Herpesvirus Detection in Blood of Individuals with Autism Spectrum Disorder and Controls</article-title>
<source/>J. Autism Dev. Disord.
          <year>2019</year>
<volume>49</volume>
<fpage>410</fpage>
<lpage>414</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-018-3691-x</pub-id>
<pub-id pub-id-type="pmid">30047098</pub-id>
</element-citation>
</ref>
<ref id="B6-brainsci-10-00200">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Libbey</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Sweeten</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Fujinami</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Autistic disorder and viral infections</article-title>
<source/>J. Neurovirol.
          <year>2005</year>
<volume>11</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1080/13550280590900553</pub-id>
</element-citation>
</ref>
<ref id="B7-brainsci-10-00200">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>P.H.</given-names>
</name>
</person-group>
<article-title>Maternal infection and immune involvement in autism</article-title>
<source/>Trends Mol. Med.
          <year>2011</year>
<volume>17</volume>
<fpage>389</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2011.03.001</pub-id>
<pub-id pub-id-type="pmid">21482187</pub-id>
</element-citation>
</ref>
<ref id="B8-brainsci-10-00200">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zerbo</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Grether</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Van de Water</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Maternal Infection during Pregnancy and Autism Spectrum Disorders</article-title>
<source/>J. Autism Dev. Disord.
          <year>2015</year>
<volume>45</volume>
<fpage>4015</fpage>
<lpage>4025</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-013-2016-3</pub-id>
<pub-id pub-id-type="pmid">24366406</pub-id>
</element-citation>
</ref>
<ref id="B9-brainsci-10-00200">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>P.H.</given-names>
</name>
</person-group>
<article-title>Maternal infection and autism</article-title>
<source/>Brain Behav. Immun.
          <year>2012</year>
<volume>17</volume>
<fpage>389</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2011.09.008</pub-id>
</element-citation>
</ref>
<ref id="B10-brainsci-10-00200">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Santis</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Brera</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mezzelani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Soricelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ciceri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Moretti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Debegnach</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bonaglia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Molteni</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of mycotoxins in the pathobiology of autism: A first evidence</article-title>
<source/>Nutr. Neurosci.
          <year>2019</year>
<volume>22</volume>
<fpage>132</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1080/1028415X.2017.1357793</pub-id>
<pub-id pub-id-type="pmid">28795659</pub-id>
</element-citation>
</ref>
<ref id="B11-brainsci-10-00200">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Santis</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Raggi</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Moretti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Facchiano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mezzelani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bonfanti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Campioni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Camposeo</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Study on the association among mycotoxins and other variables in children with autism</article-title>
<source/>Toxins
          <year>2017</year>
<volume>9</volume>
<elocation-id>203</elocation-id>
<pub-id pub-id-type="doi">10.3390/toxins9070203</pub-id>
<pub-id pub-id-type="pmid">28661468</pub-id>
</element-citation>
</ref>
<ref id="B12-brainsci-10-00200">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Ashar</surname>
<given-names>F.N.</given-names>
</name>
<name>
<surname>Moes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>West</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Arking</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism</article-title>
<source/>Nat. Commun.
          <year>2014</year>
<volume>5</volume>
<fpage>5748</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms6748</pub-id>
<pub-id pub-id-type="pmid">25494366</pub-id>
</element-citation>
</ref>
<ref id="B13-brainsci-10-00200">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellis</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Panitch</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>West</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Arking</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>Transcriptome analysis of cortical tissue reveals shared sets of downregulated genes in autism and schizophrenia</article-title>
<source/>Transl. Psychiatry
          <year>2016</year>
<volume>6</volume>
<fpage>e817</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.87</pub-id>
<pub-id pub-id-type="pmid">27219343</pub-id>
</element-citation>
</ref>
<ref id="B14-brainsci-10-00200">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voineagu</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mill</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cantor</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Blencowe</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D.H.</given-names>
</name>
</person-group>
<article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title>
<source/>Nature
          <year>2011</year>
<volume>474</volume>
<fpage>380</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1038/nature10110</pub-id>
<pub-id pub-id-type="pmid">21614001</pub-id>
</element-citation>
</ref>
<ref id="B15-brainsci-10-00200">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginsberg</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Natowicz</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Patterning of regional gene expression in autism: New complexity</article-title>
<source/>Sci. Rep.
          <year>2013</year>
<volume>3</volume>
<fpage>1</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1038/srep01831</pub-id>
</element-citation>
</ref>
<ref id="B16-brainsci-10-00200">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginsberg</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Falcone</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ting</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Natowicz</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Brain Transcriptional and Epigenetic Associations with Autism</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<pub-id pub-id-type="doi">10.1371/journal.pone.0044736</pub-id>
</element-citation>
</ref>
<ref id="B17-brainsci-10-00200">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Euskirchen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ziskin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Urban</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hallmayer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Integrated systems analysis reveals a molecular network underlying autism spectrum disorders</article-title>
<source/>Mol. Syst. Biol.
          <year>2014</year>
<volume>10</volume>
<pub-id pub-id-type="doi">10.15252/msb.20145487</pub-id>
</element-citation>
</ref>
<ref id="B18-brainsci-10-00200">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irimia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Weatheritt</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Parikshak</surname>
<given-names>N.N.</given-names>
</name>
<name>
<surname>Gonatopoulos-Pournatzis</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Babor</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Quesnel-Vallières</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tapial</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>O’Hanlon</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A highly conserved program of neuronal microexons is misregulated in autistic brains</article-title>
<source/>Cell
          <year>2014</year>
<volume>159</volume>
<fpage>1511</fpage>
<lpage>1523</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.11.035</pub-id>
<pub-id pub-id-type="pmid">25525873</pub-id>
</element-citation>
</ref>
<ref id="B19-brainsci-10-00200">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wright</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Rajpurohit</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Deep-Soboslay</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Collado-Torres</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brandon</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Hyde</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Kleinman</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Jaffe</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>A.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered expression of histamine signaling genes in autism spectrum disorder</article-title>
<source/>Transl. Psychiatry
          <year>2017</year>
<volume>7</volume>
<fpage>e1126</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2017.87</pub-id>
<pub-id pub-id-type="pmid">28485729</pub-id>
</element-citation>
</ref>
<ref id="B20-brainsci-10-00200">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregg</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Lit</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Baron</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Ozonoff</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pessah</surname>
<given-names>I.N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene expression changes in children with autism</article-title>
<source/>Genomics
          <year>2008</year>
<volume>91</volume>
<fpage>22</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.ygeno.2007.09.003</pub-id>
<pub-id pub-id-type="pmid">18006270</pub-id>
</element-citation>
</ref>
<ref id="B21-brainsci-10-00200">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pramparo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Marinero</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Solso</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mayo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dale</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ahrens-Barbeau</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cell cycle networks link gene expression dysregulation, mutation, and brain maldevelopment in autistic toddlers</article-title>
<source/>Mol. Syst. Biol.
          <year>2015</year>
<volume>11</volume>
<pub-id pub-id-type="doi">10.15252/msb.20156108</pub-id>
<pub-id pub-id-type="pmid">26668231</pub-id>
</element-citation>
</ref>
<ref id="B22-brainsci-10-00200">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pramparo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Marinero</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ahrens-Barbeau</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Courchesne</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Prediction of autism by translation and immune/inflammation coexpressed genes in toddlers from pediatric community practices</article-title>
<source/>JAMA Psychiatry
          <year>2015</year>
<volume>72</volume>
<fpage>386</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.3008</pub-id>
<pub-id pub-id-type="pmid">25739104</pub-id>
</element-citation>
</ref>
<ref id="B23-brainsci-10-00200">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Shimizu-Motohashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Holm</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Brewster</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>K.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characteristics and Predictive Value of Blood Transcriptome Signature in Males with Autism Spectrum Disorders</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<pub-id pub-id-type="doi">10.1371/journal.pone.0049475</pub-id>
<pub-id pub-id-type="pmid">23227143</pub-id>
</element-citation>
</ref>
<ref id="B24-brainsci-10-00200">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuleshov</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Rouillard</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>N.F.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Koplev</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Jagodnik</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Lachmann</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enrichr: A comprehensive gene set enrichment analysis web server 2016 update</article-title>
<source/>Nucleic Acids Res.
          <year>2016</year>
<volume>44</volume>
<fpage>W90</fpage>
<lpage>W97</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id>
<pub-id pub-id-type="pmid">27141961</pub-id>
</element-citation>
</ref>
<ref id="B25-brainsci-10-00200">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanehisa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Furumichi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Morishima</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>KEGG: New perspectives on genomes, pathways, diseases and drugs</article-title>
<source/>Nucleic Acids Res.
          <year>2017</year>
<volume>45</volume>
<fpage>D353</fpage>
<lpage>D361</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkw1092</pub-id>
<pub-id pub-id-type="pmid">27899662</pub-id>
</element-citation>
</ref>
<ref id="B26-brainsci-10-00200">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krishnan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Theesfeld</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Tadych</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Volfovsky</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Packer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Troyanskaya</surname>
<given-names>O.G.</given-names>
</name>
</person-group>
<article-title>Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder</article-title>
<source/>Nat. Neurosci.
          <year>2016</year>
<volume>19</volume>
<fpage>1454</fpage>
<pub-id pub-id-type="doi">10.1038/nn.4353</pub-id>
<pub-id pub-id-type="pmid">27479844</pub-id>
</element-citation>
</ref>
<ref id="B27-brainsci-10-00200">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tick</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Happé</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rijsdijk</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Heritability of autism spectrum disorders: A meta-analysis of twin studies</article-title>
<source/>J. Child Psychol. Psychiatry
          <year>2016</year>
<volume>57</volume>
<fpage>585</fpage>
<lpage>595</lpage>
<pub-id pub-id-type="doi">10.1111/jcpp.12499</pub-id>
<pub-id pub-id-type="pmid">26709141</pub-id>
</element-citation>
</ref>
<ref id="B28-brainsci-10-00200">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenberg</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Yenokyan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>McGready</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Characteristics and concordance of autism spectrum disorders among 277 twin pairs</article-title>
<source/>Arch. Pediatr. Adolesc. Med.
          <year>2009</year>
<volume>163</volume>
<fpage>907</fpage>
<lpage>914</lpage>
<pub-id pub-id-type="doi">10.1001/archpediatrics.2009.98</pub-id>
<pub-id pub-id-type="pmid">19805709</pub-id>
</element-citation>
</ref>
<ref id="B29-brainsci-10-00200">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Candido</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lupo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pennisi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Anfuso</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gattuso</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vivarelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Spandidos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Libra</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer’s disease</article-title>
<source/>Oncol. Rep.
          <year>2019</year>
<volume>42</volume>
<fpage>911</fpage>
<lpage>922</lpage>
<pub-id pub-id-type="doi">10.3892/or.2019.7215</pub-id>
<pub-id pub-id-type="pmid">31322245</pub-id>
</element-citation>
</ref>
<ref id="B30-brainsci-10-00200">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lombardo</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nania</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine</article-title>
<source/>Brain Sci.
          <year>2019</year>
<volume>9</volume>
<elocation-id>172</elocation-id>
<pub-id pub-id-type="doi">10.3390/brainsci9070172</pub-id>
</element-citation>
</ref>
<ref id="B31-brainsci-10-00200">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lombardo</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Presti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Libra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Candido</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling</article-title>
<source/>Brain Sci.
          <year>2019</year>
<volume>9</volume>
<elocation-id>221</elocation-id>
<pub-id pub-id-type="doi">10.3390/brainsci9090221</pub-id>
<pub-id pub-id-type="pmid">31480495</pub-id>
</element-citation>
</ref>
<ref id="B32-brainsci-10-00200">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Falzone</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression</article-title>
<source/>Exp. Ther. Med.
          <year>2019</year>
<volume>18</volume>
<fpage>2055</fpage>
<lpage>2062</lpage>
<pub-id pub-id-type="doi">10.3892/etm.2019.7774</pub-id>
<pub-id pub-id-type="pmid">31410161</pub-id>
</element-citation>
</ref>
<ref id="B33-brainsci-10-00200">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lombardo</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy</article-title>
<source/>Genes
          <year>2019</year>
<volume>10</volume>
<elocation-id>939</elocation-id>
<pub-id pub-id-type="doi">10.3390/genes10110939</pub-id>
<pub-id pub-id-type="pmid">31752120</pub-id>
</element-citation>
</ref>
<ref id="B34-brainsci-10-00200">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lombardo</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Campo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Corsico</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Presti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis</article-title>
<source/>Int. J. Mol. Sci.
          <year>2019</year>
<volume>20</volume>
<elocation-id>4323</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms20184323</pub-id>
<pub-id pub-id-type="pmid">31487788</pub-id>
</element-citation>
</ref>
<ref id="B35-brainsci-10-00200">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Cutuli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Di Marco</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Scandurra</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Saraceno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Mangano Effects of Treatment with the Hypomethylating Agent 5-aza-2’-deoxycytidine in Murine Type II Collagen-Induced Arthritis</article-title>
<source/>Pharmaceuticals
          <year>2019</year>
<volume>12</volume>
<elocation-id>174</elocation-id>
<pub-id pub-id-type="doi">10.3390/ph12040174</pub-id>
</element-citation>
</ref>
<ref id="B36-brainsci-10-00200">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Di Marco</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Spinasanta</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Identification of CD4<sup>+</sup> T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment</article-title>
<source/>Mol. Med. Rep.
          <year>2019</year>
<volume>20</volume>
<fpage>678</fpage>
<lpage>684</lpage>
<pub-id pub-id-type="doi">10.3892/mmr.2019.10283</pub-id>
<pub-id pub-id-type="pmid">31180553</pub-id>
</element-citation>
</ref>
<ref id="B37-brainsci-10-00200">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Scalabrino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF</article-title>
<source/>J. Neuroimmunol.
          <year>2019</year>
<volume>332</volume>
<fpage>224</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2019.05.006</pub-id>
<pub-id pub-id-type="pmid">31100693</pub-id>
</element-citation>
</ref>
<ref id="B38-brainsci-10-00200">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Di Marco</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Upregulated Expression of Macrophage Migration Inhibitory Factor, Its Analogue D-Dopachrome Tautomerase, and the CD44 Receptor in Peripheral CD4 T Cells from Clinically Isolated Syndrome Patients with Rapid Conversion to Clinical Defined Multiple Sclerosis</article-title>
<source/>Medicina
          <year>2019</year>
<volume>55</volume>
<elocation-id>667</elocation-id>
<pub-id pub-id-type="doi">10.3390/medicina55100667</pub-id>
</element-citation>
</ref>
<ref id="B39-brainsci-10-00200">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pennisi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kalfin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Martinovic</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ivanovic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Andabaka</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In Silico and in vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod</article-title>
<source/>Molecules
          <year>2019</year>
<volume>25</volume>
<elocation-id>20</elocation-id>
<pub-id pub-id-type="doi">10.3390/molecules25010020</pub-id>
</element-citation>
</ref>
<ref id="B40-brainsci-10-00200">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Günther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jalce</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Atanasov</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Guignabert</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: From pathogenic factors to therapeutic targets</article-title>
<source/>Drug Discov. Today
          <year>2019</year>
<volume>24</volume>
<fpage>428</fpage>
<lpage>439</lpage>
<pub-id pub-id-type="doi">10.1016/j.drudis.2018.11.003</pub-id>
<pub-id pub-id-type="pmid">30439447</pub-id>
</element-citation>
</ref>
<ref id="B41-brainsci-10-00200">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pennisi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Impaired Expression of Tetraspanin 32 (TSPAN32) in Memory T Cells of Patients with Multiple Sclerosis</article-title>
<source/>Brain Sci.
          <year>2020</year>
<volume>10</volume>
<elocation-id>52</elocation-id>
<pub-id pub-id-type="doi">10.3390/brainsci10010052</pub-id>
<pub-id pub-id-type="pmid">31963428</pub-id>
</element-citation>
</ref>
<ref id="B42-brainsci-10-00200">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Di Marco</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Barcellona</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Salvatorelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Magro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats</article-title>
<source/>Clin. Immunol.
          <year>2015</year>
<volume>157</volume>
<fpage>198</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1016/j.clim.2015.02.002</pub-id>
<pub-id pub-id-type="pmid">25701800</pub-id>
</element-citation>
</ref>
<ref id="B43-brainsci-10-00200">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma</article-title>
<source/>Brain Sci.
          <year>2019</year>
<volume>9</volume>
<elocation-id>284</elocation-id>
<pub-id pub-id-type="doi">10.3390/brainsci9100284</pub-id>
<pub-id pub-id-type="pmid">31635049</pub-id>
</element-citation>
</ref>
<ref id="B44-brainsci-10-00200">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Avitabile</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reibaldi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma</article-title>
<source/>Molecules
          <year>2019</year>
<volume>24</volume>
<elocation-id>2450</elocation-id>
<pub-id pub-id-type="doi">10.3390/molecules24132450</pub-id>
<pub-id pub-id-type="pmid">31277366</pub-id>
</element-citation>
</ref>
<ref id="B45-brainsci-10-00200">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Caltabiano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pesce</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Puleo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Atanasov</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Magro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis</article-title>
<source/>J. Cell. Physiol.
          <year>2018</year>
<volume>233</volume>
<fpage>4156</fpage>
<lpage>4165</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.26223</pub-id>
<pub-id pub-id-type="pmid">29034470</pub-id>
</element-citation>
</ref>
<ref id="B46-brainsci-10-00200">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>McCubrey</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis</article-title>
<source/>Oncotarget
          <year>2018</year>
<volume>9</volume>
<fpage>8263</fpage>
<lpage>8277</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.23862</pub-id>
<pub-id pub-id-type="pmid">29492193</pub-id>
</element-citation>
</ref>
<ref id="B47-brainsci-10-00200">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets</article-title>
<source/>Int. J. Mol. Sci.
          <year>2018</year>
<volume>19</volume>
<elocation-id>831</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms19030831</pub-id>
</element-citation>
</ref>
<ref id="B48-brainsci-10-00200">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Lenzo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Quattropani</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Bendtzen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches</article-title>
<source/>J. Affect. Disord.
          <year>2020</year>
<volume>263</volume>
<fpage>15</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2019.11.127</pub-id>
<pub-id pub-id-type="pmid">31818772</pub-id>
</element-citation>
</ref>
<ref id="B49-brainsci-10-00200">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pesce</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pesce</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Caltabiano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Giorlandino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rosanna Portale</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>G.A.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of novel targets for the diagnosis and treatment of liver fibrosis</article-title>
<source/>Int. J. Mol. Med.
          <year>2015</year>
<volume>36</volume>
<fpage>747</fpage>
<lpage>752</lpage>
<pub-id pub-id-type="doi">10.3892/ijmm.2015.2264</pub-id>
<pub-id pub-id-type="pmid">26135677</pub-id>
</element-citation>
</ref>
<ref id="B50-brainsci-10-00200">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Krajnovic</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Draca</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Al-Abed</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mijatovic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maksimovic-Ivanic</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells</article-title>
<source/>Molecules
          <year>2018</year>
<volume>23</volume>
<elocation-id>2463</elocation-id>
<pub-id pub-id-type="doi">10.3390/molecules23102463</pub-id>
</element-citation>
</ref>
<ref id="B51-brainsci-10-00200">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petralia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pennisi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Saraceno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease: Conventionally Pathogenetic or Unconventionally Protective?</article-title>
<source/>Molecules
          <year>2020</year>
<volume>25</volume>
<elocation-id>291</elocation-id>
<pub-id pub-id-type="doi">10.3390/molecules25020291</pub-id>
<pub-id pub-id-type="pmid">31936865</pub-id>
</element-citation>
</ref>
<ref id="B52-brainsci-10-00200">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gugliandolo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Silvestro</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pollastro</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol</article-title>
<source/>Medicina
          <year>2019</year>
<volume>55</volume>
<elocation-id>747</elocation-id>
<pub-id pub-id-type="doi">10.3390/medicina55110747</pub-id>
<pub-id pub-id-type="pmid">31752240</pub-id>
</element-citation>
</ref>
<ref id="B53-brainsci-10-00200">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schepici</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bramanti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Mazzon Autism Spectrum Disorder and miRNA: An Overview of Experimental Models</article-title>
<source/>Brain Sci.
          <year>2019</year>
<volume>9</volume>
<elocation-id>265</elocation-id>
<pub-id pub-id-type="doi">10.3390/brainsci9100265</pub-id>
<pub-id pub-id-type="pmid">31623367</pub-id>
</element-citation>
</ref>
<ref id="B54-brainsci-10-00200">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paskaš</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Krajnović</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Dunđerović</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Al-Abed</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mijatović</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma</article-title>
<source/>Mol. Carcinog.
          <year>2019</year>
<volume>58</volume>
<fpage>1362</fpage>
<lpage>1375</lpage>
<pub-id pub-id-type="doi">10.1002/mc.23020</pub-id>
<pub-id pub-id-type="pmid">30997718</pub-id>
</element-citation>
</ref>
<ref id="B55-brainsci-10-00200">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paskas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mazzon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Al-Abed</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rakocevic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mijatovic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maksimovic-Ivanic</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo</article-title>
<source/>Investig. New Drugs
          <year>2019</year>
<volume>37</volume>
<fpage>1014</fpage>
<lpage>1028</lpage>
<pub-id pub-id-type="doi">10.1007/s10637-019-00733-3</pub-id>
<pub-id pub-id-type="pmid">30706336</pub-id>
</element-citation>
</ref>
<ref id="B56-brainsci-10-00200">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fagone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mangano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Quattrocchi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mammana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>G.A.G.</given-names>
</name>
<name>
<surname>Pennisi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zocca</surname>
<given-names>M.-B.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Al-Abed</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir</article-title>
<source/>Basic Clin. Pharmacol. Toxicol.
          <year>2015</year>
<volume>117</volume>
<fpage>306</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="doi">10.1111/bcpt.12414</pub-id>
<pub-id pub-id-type="pmid">25903922</pub-id>
</element-citation>
</ref>
<ref id="B57-brainsci-10-00200">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maksimovic-Ivanic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mojic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bulatovic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Radojkovic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuzmanovic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ristic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stosic-Grujicic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miljkovic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cavalli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Libra</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K</article-title>
<source/>Leuk. Res.
          <year>2015</year>
<volume>39</volume>
<fpage>1088</fpage>
<lpage>1095</lpage>
<pub-id pub-id-type="doi">10.1016/j.leukres.2015.06.013</pub-id>
<pub-id pub-id-type="pmid">26220866</pub-id>
</element-citation>
</ref>
<ref id="B58-brainsci-10-00200">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atladóttir</surname>
<given-names>H.Ó.</given-names>
</name>
<name>
<surname>Henriksen</surname>
<given-names>T.B.</given-names>
</name>
<name>
<surname>Schendel</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Parner</surname>
<given-names>E.T.</given-names>
</name>
</person-group>
<article-title>Autism after infection, febrile episodes, and antibiotic use during pregnancy: An exploratory study</article-title>
<source/>Pediatrics
          <year>2012</year>
<volume>130</volume>
<fpage>e1447</fpage>
<lpage>e1454</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2012-1107</pub-id>
<pub-id pub-id-type="pmid">23147969</pub-id>
</element-citation>
</ref>
<ref id="B59-brainsci-10-00200">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Magnusson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Blomström</surname>
<given-names>Å.</given-names>
</name>
<name>
<surname>Newschaffer</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Burstyn</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Karlsson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dalman</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders</article-title>
<source/>Brain Behav. Immun.
          <year>2015</year>
<volume>44</volume>
<fpage>100</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2014.09.001</pub-id>
<pub-id pub-id-type="pmid">25218900</pub-id>
</element-citation>
</ref>
<ref id="B60-brainsci-10-00200">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engman</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Sundin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miniscalco</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Westerlund</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lewensohn-Fuchs</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fernell</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Prenatal acquired cytomegalovirus infection should be considered in children with autism</article-title>
<source/>Acta Paediatr.
          <year>2015</year>
<volume>104</volume>
<fpage>792</fpage>
<lpage>795</lpage>
<pub-id pub-id-type="doi">10.1111/apa.13032</pub-id>
<pub-id pub-id-type="pmid">25900322</pub-id>
</element-citation>
</ref>
<ref id="B61-brainsci-10-00200">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Odeberg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wolmer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Falci</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Westgren</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sundtröm</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Seiger</surname>
<given-names>Å.</given-names>
</name>
<name>
<surname>Söderberg-Nauclér</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Late human cytomegalovirus (HCMV) proteins inhibit differentiation of human neural precursor cells into astrocytes</article-title>
<source/>J. Neurosci. Res.
          <year>2007</year>
<volume>85</volume>
<fpage>583</fpage>
<lpage>893</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.21144</pub-id>
<pub-id pub-id-type="pmid">17154414</pub-id>
</element-citation>
</ref>
<ref id="B62-brainsci-10-00200">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Odeberg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wolmer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Falci</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Westgren</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Seiger</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Soderberg-Naucler</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Human Cytomegalovirus Inhibits Neuronal Differentiation and Induces Apoptosis in Human Neural Precursor Cells</article-title>
<source/>J. Virol.
          <year>2006</year>
<volume>80</volume>
<fpage>8929</fpage>
<lpage>8939</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.00676-06</pub-id>
<pub-id pub-id-type="pmid">16940505</pub-id>
</element-citation>
</ref>
<ref id="B63-brainsci-10-00200">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spann</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Sourander</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Surcel</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Hinkka-Yli-Salomäki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Prenatal toxoplasmosis antibody and childhood autism</article-title>
<source/>Autism Res.
          <year>2017</year>
<volume>10</volume>
<fpage>769</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1002/aur.1722</pub-id>
<pub-id pub-id-type="pmid">27874276</pub-id>
</element-citation>
</ref>
<ref id="B64-brainsci-10-00200">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prandota</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroinflammation causing persistent hypercytokinemia that resulted in an increased lipid peroxidation, oxidative stress, and depressed metabolism of endogenous and exo</article-title>
<source/>Res. Autism Spectr. Disord.
          <year>2010</year>
<volume>4</volume>
<fpage>119</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="doi">10.1016/j.rasd.2009.09.011</pub-id>
</element-citation>
</ref>
<ref id="B65-brainsci-10-00200">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Farrington</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Petropoulos</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Favot-Mayaud</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Waight</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association</article-title>
<source/>Lancet
          <year>1999</year>
<volume>353</volume>
<fpage>2026</fpage>
<lpage>2029</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(99)01239-8</pub-id>
<pub-id pub-id-type="pmid">10376617</pub-id>
</element-citation>
</ref>
<ref id="B66-brainsci-10-00200">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kałuzna-Czaplińska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Błaszczyk</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The level of arabinitol in autistic children after probiotic therapy</article-title>
<source/>Nutrition
          <year>2012</year>
<volume>28</volume>
<fpage>124</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="doi">10.1016/j.nut.2011.08.002</pub-id>
<pub-id pub-id-type="pmid">22079796</pub-id>
</element-citation>
</ref>
<ref id="B67-brainsci-10-00200">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaw</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia</article-title>
<source/>Nutr. Neurosci.
          <year>2010</year>
<volume>13</volume>
<fpage>135</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.1179/147683010X12611460763968</pub-id>
<pub-id pub-id-type="pmid">20423563</pub-id>
</element-citation>
</ref>
<ref id="B68-brainsci-10-00200">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flegr</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Horáček</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Negative Effects of Latent Toxoplasmosis on Mental Health</article-title>
<source/>Front. Psychiatry
          <year>2020</year>
<volume>10</volume>
<fpage>1012</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2019.01012</pub-id>
<pub-id pub-id-type="pmid">32132937</pub-id>
</element-citation>
</ref>
<ref id="B69-brainsci-10-00200">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valayi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Eftekharian</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Taheri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alikhani</surname>
<given-names>M.Y.</given-names>
</name>
</person-group>
<article-title>Evaluation of antibodies to cytomegalovirus and Epstein-Barr virus in patients with autism spectrum disorder</article-title>
<source/>Hum. Antibodies
          <year>2017</year>
<volume>26</volume>
<fpage>165</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.3233/HAB-180335</pub-id>
<pub-id pub-id-type="pmid">29689713</pub-id>
</element-citation>
</ref>
<ref id="B70-brainsci-10-00200">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gentile</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zappulo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bonavolta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Maresca</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Riccio</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Buonomo</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Portella</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vallefuoco</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Settimi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pascotto</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders</article-title>
<source/>In Vivo
          <year>2014</year>
<volume>28</volume>
<fpage>667</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="pmid">24982239</pub-id>
</element-citation>
</ref>
<ref id="B71-brainsci-10-00200">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gentile</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zappulo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bonavolta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Portella</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cernia</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Riccio</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Settimi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pascotto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Borgia</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of HHV-6 and HHV-8 antibodies in patients with autism spectrum disorders</article-title>
<source/>In Vivo
          <year>2013</year>
<volume>27</volume>
<fpage>843</fpage>
<lpage>849</lpage>
<pub-id pub-id-type="pmid">24292591</pub-id>
</element-citation>
</ref>
<ref id="B72-brainsci-10-00200">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hickman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Izzy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Morsett</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>El Khoury</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Microglia in neurodegeneration</article-title>
<source/>Nat. Neurosci.
          <year>2018</year>
<volume>21</volume>
<fpage>1359</fpage>
<lpage>1369</lpage>
<pub-id pub-id-type="doi">10.1038/s41593-018-0242-x</pub-id>
<pub-id pub-id-type="pmid">30258234</pub-id>
</element-citation>
</ref>
<ref id="B73-brainsci-10-00200">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grant</surname>
<given-names>S.G.N.</given-names>
</name>
<name>
<surname>Karl</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Kiebler</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Kandel</surname>
<given-names>E.R.</given-names>
</name>
</person-group>
<article-title>Focal adhesion kinase in the brain: Novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice</article-title>
<source/>Genes Dev.
          <year>1995</year>
<volume>9</volume>
<fpage>1909</fpage>
<lpage>1921</lpage>
<pub-id pub-id-type="doi">10.1101/gad.9.15.1909</pub-id>
<pub-id pub-id-type="pmid">7544314</pub-id>
</element-citation>
</ref>
<ref id="B74-brainsci-10-00200">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olive</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dubois</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schachner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rougon</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>The F3 Neuronal Glycosylphosphatidylinositol-Linked Molecule Is Localized to Glycolipid-Enriched Membrane Subdomains and Interacts with L1 and Fyn Kinase in Cerebellum</article-title>
<source/>J. Neurochem.
          <year>1995</year>
<volume>65</volume>
<fpage>2307</fpage>
<lpage>2317</lpage>
<pub-id pub-id-type="doi">10.1046/j.1471-4159.1995.65052307.x</pub-id>
<pub-id pub-id-type="pmid">7595520</pub-id>
</element-citation>
</ref>
<ref id="B75-brainsci-10-00200">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grant</surname>
<given-names>S.G.N.</given-names>
</name>
<name>
<surname>O’Dell</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Karl</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Soriano</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kandel</surname>
<given-names>E.R.</given-names>
</name>
</person-group>
<article-title>Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice</article-title>
<source/>Science
          <year>1992</year>
<volume>258</volume>
<fpage>1903</fpage>
<lpage>1910</lpage>
<pub-id pub-id-type="doi">10.1126/science.1361685</pub-id>
<pub-id pub-id-type="pmid">1361685</pub-id>
</element-citation>
</ref>
<ref id="B76-brainsci-10-00200">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waterhouse</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Genes tPA, Fyn, and FAK in autism?</article-title>
<source/>J. Autism Dev. Disord.
          <year>1997</year>
<volume>27</volume>
<fpage>220</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="pmid">9105973</pub-id>
</element-citation>
</ref>
<ref id="B77-brainsci-10-00200">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celestino-Soper</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schroer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shenai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nowaczyk</surname>
<given-names>M.M.J.</given-names>
</name>
<name>
<surname>Terespolsky</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cushing</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Immken</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deletions in chromosome 6p22.3–p24.3, including ATXN1, are associated with developmental delay and autism spectrum disorders</article-title>
<source/>Mol. Cytogenet.
          <year>2012</year>
<volume>5</volume>
<fpage>17</fpage>
<pub-id pub-id-type="doi">10.1186/1755-8166-5-17</pub-id>
<pub-id pub-id-type="pmid">22480366</pub-id>
</element-citation>
</ref>
<ref id="B78-brainsci-10-00200">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Benedetto</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Di Vita</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lo Giudice</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vitello</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Zingale</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grillo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Castiglia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Musumeci</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Fichera</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>6p22.3 deletion: Report of a patient with autism, severe intellectual disability and electroencephalographic anomalies</article-title>
<source/>Mol. Cytogenet.
          <year>2013</year>
<volume>6</volume>
<fpage>4</fpage>
<pub-id pub-id-type="doi">10.1186/1755-8166-6-4</pub-id>
<pub-id pub-id-type="pmid">23324214</pub-id>
</element-citation>
</ref>
<ref id="B79-brainsci-10-00200">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Rousseaux</surname>
<given-names>M.W.C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Richman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Y.W.</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans</article-title>
<source/>Nat. Genet.
          <year>2017</year>
<volume>49</volume>
<fpage>527</fpage>
<lpage>536</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3808</pub-id>
<pub-id pub-id-type="pmid">28288114</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="brainsci-10-00200-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Infection-related pathways enriched in brain samples from ASD patients. Dotted line indicates the threshold of significance.</p>
</caption>
<graphic xlink:href="brainsci-10-00200-g001"></graphic>
</fig>
<fig id="brainsci-10-00200-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>“Prion diseases pathway” from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database with genes significantly modulated in brain samples from ASD patients that have been color-coded from blue (downregulated) to red (upregulated).</p>
</caption>
<graphic xlink:href="brainsci-10-00200-g002"></graphic>
</fig>
<fig id="brainsci-10-00200-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Immune-related pathways enriched in brain samples from ASD patients. Dotted line indicates the threshold of significance.</p>
</caption>
<graphic xlink:href="brainsci-10-00200-g003"></graphic>
</fig>
<fig id="brainsci-10-00200-f004" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>Network constructed using the differentially expressed genes in the ASD brain belonging to the “prion diseases” pathway using a minimum confidence score of 0.04 and a maximum of 20 interacting genes.</p>
</caption>
<graphic xlink:href="brainsci-10-00200-g004"></graphic>
</fig>
<table-wrap id="brainsci-10-00200-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">brainsci-10-00200-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Characteristics of the datasets used in the meta-analyses.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Dataset ID</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="top">Tissue</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="top">Samples</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="top">Platform</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">GSE28521</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Temporal cortex</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 13 ASD <break></break><italic>n</italic> = 13 HD *</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Illumina HumanRef-8 v3.0 Expression BeadChip</td>
<td align="left" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B14-brainsci-10-00200">14</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Frontal cortex</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 16 ASD <break></break><italic>n</italic> = 16 HD *</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cerebellum</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 10 ASD <break></break><italic>n</italic> = 11 HD *</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">GSE38322</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Occipital cortex (BA19)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 6 ASD <break></break><italic>n</italic> = 4 HD *</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Illumina HumanHT-12 V4.0 Expression BeadChip</td>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B15-brainsci-10-00200">15</xref>]<break></break>[<xref ref-type="bibr" rid="B16-brainsci-10-00200">16</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cerebellum</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 8 ASD <break></break><italic>n</italic> = 8 HD *</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GSE62098</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Corpus callosum</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 6 ASD <break></break><italic>n</italic> = 6 HD *</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Illumina HiSeq 2000 (<italic>Homo sapiens</italic>)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B17-brainsci-10-00200">17</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GSE64018</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Superior temporal gyrus</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 12 ASD <break></break><italic>n</italic> = 12 HD *</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Illumina HiSeq 2000 (<italic>Homo sapiens</italic>)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B18-brainsci-10-00200">18</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GSE102741</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Dorsolateral prefrontal cortex</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 13 ASD <break></break><italic>n</italic> = 39 HD *</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Illumina HiSeq 2000 (<italic>Homo sapiens</italic>)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B19-brainsci-10-00200">19</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GSE6575</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Whole blood</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 35 ASD <break></break><italic>n</italic> = 12 HD *</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Affymetrix Human Genome U133 Plus 2.0 Array</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B20-brainsci-10-00200">20</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GSE42133</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Leukocytes</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 91 ASD <break></break><italic>n</italic> = 56 HD *</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Illumina HumanHT-12 V4.0 Expression BeadChip</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B21-brainsci-10-00200">21</xref>]<break></break>[<xref ref-type="bibr" rid="B22-brainsci-10-00200">22</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GSE18123</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Whole blood</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 31 ASD <break></break><italic>n</italic> = 33 HD *</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Affymetrix Human Genome U133 Plus 2.0 Array</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B23-brainsci-10-00200">23</xref>]</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>* HD: Healthy donors.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="brainsci-10-00200-t002" orientation="portrait" position="float">
<object-id pub-id-type="pii">brainsci-10-00200-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>Top 10 enriched KEGG pathways in brain samples from ASD patients.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Term</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle"><italic>p</italic> Value</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Adj. <italic>p</italic>-Value</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Odds Ratio</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Combined Score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Synaptic vesicle cycle</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">8.95E-04</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.030642</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3.975353</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">27.90006</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Huntington’s disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">5.06E-04</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.031192</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2.811584</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">21.33503</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sphingolipid signaling pathway</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.001034</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.031855</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3.257117</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">22.38962</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Thyroid hormone signaling pathway</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">8.49E-04</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.03269</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3.341353</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">23.62788</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Parkinson’s disease</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3.20E-04</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.032842</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3.275467</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">26.35943</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gap junction</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">4.43E-04</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.034103</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3.964059</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">30.61119</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">VEGF signaling pathway</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">7.81E-04</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.034369</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">4.598607</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">32.90204</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prion diseases</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2.46E-04</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.037893</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">6.644518</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">55.21555</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Valine, leucine and isoleucine degradation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.001402</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.03926</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">4.844961</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">31.83014</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lysine degradation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">7.81E-04</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.040097</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">4.598607</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">32.90204</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="brainsci-10-00200-t003" orientation="portrait" position="float">
<object-id pub-id-type="pii">brainsci-10-00200-t003_Table 3</object-id>
<label>Table 3</label>
<caption>
<p>Top 10 genes interacting with ASD brain DEGs belonging to the “prion diseases” pathway.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Query Gene</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene Description</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Edge Score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HSPA5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MANF</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">mesencephalic astrocyte-derived neurotrophic factor</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.791</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HSPA5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HSP90B1</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">heat shock protein 90kDa beta (Grp94), member 1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.79</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MAP2K1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MAPK1</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">mitogen-activated protein kinase 1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.789</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HSPA5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">RAB1A</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">RAB1A, member RAS oncogene family</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.761</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MAP2K1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PGK1</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">phosphoglycerate kinase 1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.728</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MAP2K1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">YWHAZ</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.706</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">FYN</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ATXN1</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ataxin 1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.705</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HSPA5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ARF4</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ADP-ribosylation factor 4</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.702</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HSPA5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">HERPUD1</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.69</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">LAMC1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AKT3</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">v-akt murine thymoma viral oncogene homolog 3</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.669</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="brainsci-10-00200-t004" orientation="portrait" position="float">
<object-id pub-id-type="pii">brainsci-10-00200-t004_Table 4</object-id>
<label>Table 4</label>
<caption>
<p>Top 10 ranking ASD genes interacting with brain DEGs belonging to the “prion diseases” pathway.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Description</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Avg. Edge Score to Query</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Rank</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Probability of ASD Association</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle"><italic>p</italic>-Value</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">q-Value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ATXN1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ataxin 1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.216</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.828</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.002</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.0186</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GNB1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">guanine nucleotide binding protein (G protein), beta polypeptide 1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.231</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">24</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.811</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.001</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.0113</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AKT3</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">v-akt murine thymoma viral oncogene homolog 3</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.205</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">75</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.722</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.001</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.0113</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">YWHAB</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.176</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">107</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.71</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.0438</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">YWHAZ</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.212</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">269</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.697</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.08</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.3199</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">RAB1A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">RAB1A, member RAS oncogene family</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.257</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">453</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.696</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.066</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.2786</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MACF1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">microtubule-actin crosslinking factor 1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.205</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">715</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.667</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.005</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.0381</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PPIB</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">peptidylprolyl isomerase B (cyclophilin B)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.152</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">753</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.666</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.221</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.6426</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">BHLHE40</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">basic helix-loop-helix family, member e40</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.187</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1054</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.663</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.149</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.4976</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MAPK1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">mitogen-activated protein kinase 1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.234</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1128</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.661</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.133</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.4605</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="brainsci-10-00200-t005" orientation="portrait" position="float">
<object-id pub-id-type="pii">brainsci-10-00200-t005_Table 5</object-id>
<label>Table 5</label>
<caption>
<p>Top 10 enriched KEGG pathways in blood from ASD patients.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Term</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle"><italic>p</italic>-Value</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Adjusted <italic>p</italic>-Value</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Odds Ratio</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Combined Score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Autophagy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.01023</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.450115</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">13.02083</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">59.6672</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Osteoclast differentiation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.010077</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.517306</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">13.12336</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">60.33413</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">cGMP-PKG signaling pathway</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.016766</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.573785</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">10.04016</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">41.04796</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Tuberculosis</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.019321</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.595073</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">9.310987</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">36.74661</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Oocyte meiosis</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.009775</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.60217</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">13.33333</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">61.70503</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cellular senescence</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.015641</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.602172</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">10.41667</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">43.31114</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AMPK signaling pathway</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.009039</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.695998</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">13.88889</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">65.36409</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Thermogenesis</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.031025</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.73505</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">7.215007</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">25.05748</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Regulation of actin cytoskeleton</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.026947</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.754518</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">7.788162</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">28.14549</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Insulin resistance</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.007379</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.757574</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">15.4321</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">75.75804</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>